| DK33181A (en)* | 1980-02-06 | 1981-08-07 | Searle & Co | PROCEDURE FOR THE PREPARATION OF AN INTERFERONOUS PROTEIN |
| ZA811368B (en)* | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| IE57069B1 (en) | 1980-04-03 | 1992-04-22 | Biogen Inc | Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon |
| DE3176011D1 (en)* | 1980-06-12 | 1987-04-23 | Japan Found Cancer | Plasmid |
| DK489481A (en)* | 1980-11-10 | 1982-05-11 | Searle & Co | PLASMID VECTOR AND METHOD OF PRODUCING THEREOF |
| NZ199722A (en)* | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
| JPS58110600A (en)* | 1981-12-25 | 1983-07-01 | Kyowa Hakko Kogyo Co Ltd | Recombinant plasmid containing human beta-interferon gene |
| US5827694A (en)* | 1982-03-08 | 1998-10-27 | Genentech, Inc. | DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides |
| US4775622A (en)* | 1982-03-08 | 1988-10-04 | Genentech, Inc. | Expression, processing and secretion of heterologous protein by yeast |
| IE54592B1 (en)* | 1982-03-08 | 1989-12-06 | Genentech Inc | Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby |
| US6432677B1 (en) | 1982-03-08 | 2002-08-13 | Genentech, Inc. | Non-human animal interferons |
| AU575301B2 (en)* | 1982-10-08 | 1988-07-28 | Juridical Foundation, Japanese Foundation For Cancer Research | Novel vector |
| US5831023A (en)* | 1982-11-01 | 1998-11-03 | Genentech, Inc. | Recombinant animal interferon polypeptides |
| US4512922A (en)* | 1982-12-22 | 1985-04-23 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US4518526A (en)* | 1982-12-22 | 1985-05-21 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US4599197A (en)* | 1982-12-22 | 1986-07-08 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| GR79124B (en)* | 1982-12-22 | 1984-10-02 | Genentech Inc | |
| US4511502A (en)* | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US4620948A (en)* | 1982-12-22 | 1986-11-04 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US5683688A (en)* | 1984-05-31 | 1997-11-04 | Genentech, Inc. | Unglycosylated recombinant human lymphotoxin polypeptides and compositions |
| GB8414354D0 (en)* | 1984-06-05 | 1984-07-11 | Biogen Nv | Purifying protein |
| US5231176A (en)* | 1984-08-27 | 1993-07-27 | Genentech, Inc. | Distinct family DNA encoding of human leukocyte interferons |
| ATE47864T1 (en)* | 1984-08-27 | 1989-11-15 | Genentech Inc | MISCELLANEOUS FAMILY OF HUMAN WBC INTERFERONS, COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR PRODUCTION, AND DNA AND TRANSFECTED HOSTS THEREOF. |
| US4680262A (en)* | 1984-10-05 | 1987-07-14 | Genentech, Inc. | Periplasmic protein recovery |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| EP0237019A3 (en)* | 1986-03-14 | 1988-03-09 | Toray Industries, Inc. | Interferon conjugate and production thereof using recombinant gene |
| GB9022543D0 (en)* | 1990-10-17 | 1990-11-28 | Wellcome Found | Antibody production |
| FR2686899B1 (en) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| US20050002902A1 (en)* | 1995-12-28 | 2005-01-06 | Liming Yu | Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections |
| US5723125A (en)* | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| US20030026779A1 (en)* | 1999-10-15 | 2003-02-06 | Liming Yu | Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc |
| US6713609B1 (en) | 1996-07-16 | 2004-03-30 | Genentech, Inc. | Monoclonal antibodies to type I interferon receptor |
| JP3576819B2 (en) | 1997-07-30 | 2004-10-13 | キヤノン株式会社 | Information processing apparatus, print control method, and storage medium |
| US20030018174A1 (en)* | 1997-10-06 | 2003-01-23 | Genentech, Inc. | Monoclonal antibodies to IFNAR2 |
| AU780836B2 (en) | 1999-03-24 | 2005-04-21 | Serono Genetics Institute S.A. | Genomic sequence of the (purH) gene and (purH)-related biallelic markers |
| JP2003530838A (en) | 2000-04-12 | 2003-10-21 | ヒューマン ゲノム サイエンシズ インコーポレイテッド | Albumin fusion protein |
| US20020160974A1 (en)* | 2001-01-09 | 2002-10-31 | Banchereau Jacques F. | Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| KR101271635B1 (en)* | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | Albumin fusion proteins |
| ES2425738T3 (en) | 2001-12-21 | 2013-10-17 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
| WO2004060299A2 (en) | 2002-12-26 | 2004-07-22 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates of interferon-beta with enhanced biological potency |
| EP1628618A4 (en)* | 2002-12-26 | 2009-09-09 | Mountain View Pharmaceuticals | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| EP1594530A4 (en) | 2003-01-22 | 2006-10-11 | Human Genome Sciences Inc | Albumin fusion proteins |
| AU2005211385B2 (en) | 2004-02-02 | 2008-12-11 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
| BRPI0613306A2 (en)* | 2005-06-22 | 2010-12-28 | Genentech Inc | isolated antibodies, immunoglobulin polypeptides, ifnar2 antibody, nucleic acid molecule, host cell, cell line, antibody production method, composition, method for diagnosing the presence of ifnar2, method of treating a disease and methods |
| US9938333B2 (en) | 2008-02-08 | 2018-04-10 | Ambrx, Inc. | Modified leptin polypeptides and their uses |